Beauty Farm Medical and Health Industry Inc. disclosed that it repurchased 60,000 ordinary shares on 30 March 2026 through on-market transactions on the Hong Kong Stock Exchange.

The shares were bought at prices ranging from HKD 19.03 to HKD 19.35, translating to a volume-weighted average of HKD 19.15 per share and a total outlay of HKD 1.15 million. All repurchased shares have been moved into treasury, bringing the company’s treasury stock to 1.13 million shares.

After the transaction, the company’s outstanding shares (excluding treasury) decreased by 0.02% to 250.47 million. The total issued share count, including treasury shares, remains unchanged at 251.59 million.

The buyback was executed under the mandate approved on 27 June 2025, which authorises repurchases of up to 23.58 million shares. Cumulative repurchases under this mandate now stand at 1.13 million shares, equivalent to 0.48% of the share count at the time the mandate was granted.

In line with Hong Kong listing rules, Beauty Farm Medical is restricted from issuing new shares or selling treasury shares until 29 April 2026.